tirzepatide vial instructions These highlights do not include all the information needed to use MOUNJARO safely and effectively. See full prescribing information for MOUNJARO.MOUNJARO® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 Dosing for Tirzepatide | Optimize

Mental health side effects: emerging data This is one of the most actively researched areas in GLP-1 safety, and the data is evolving rapidly

Additionally, tirzepatide carries an FDA warning about acute gallbladder disease, which can present with similar abdominal symptoms

Rybelsus [package insert]

Increasing heart rate Worsening depression, behavior changes, or suicidality Note: Never share the Mounjaro pen with other people

There is a second rule people forget: no two doses within 72 hours of each other

Although Zepbound and Mounjaro have the same chemical compound, theyre prescribed for different purposes and were approved by the FDA to treat different medical conditions